EP Global Communications, Inc
(Pink Sheets: EPGL)
), the parent company of
) magazine, and the EP Health Sciences Division are announcing to investors that on the eve of this year’s World Conference on Disabilities (WCD), the Muscle Pain Detection Device (MPDD) has been evaluated at two major US health institutions with several more expressing interest.
“Evaluation results are positive and we anticipate the FDA approved device, coupled with Dr. Norman Marcus’ treatment protocol, will help many millions of people impacted by pain,” said Joseph M. Valenzano Jr., CEO of EP Global Communications, Inc. “Use of the MPDD can provide clinicians with information about which muscles are causing back and neck pain and help reduce the associated staggering direct medical costs - 86 billion in 2005. It just needs more awareness, which we hope to help provide.”
This announcement comes as EP Global Communications is seeing unprecedented events and developments in its 40-year history. “We are excited about recent financial restructuring agreements as well as contracts and affiliations, including those with Web MD, the United States Marine Corps and soon the US Army, and a Keynote Address by Admiral Michael Mullen, Chairman of the Joint Chiefs of Staff, to kick off this year’s World Conference on Disabilities in Dallas, Texas,” explained Valenzano.
In addition, several online educational seminars will be broadcast live on the internet free of charge and investors, subscribers, and readers are encouraged to register and attend. Among the seminars to be broadcast is the presentation by Dr. Marcus to conference attendees and those viewing live online worldwide on how a muscle evaluation and treatment protocol utilizing the MPDD can reduce disability related to neck and back pain. Other seminars such as new treatment therapies for epilepsy, including surgical interventions, will also be available.